Literature DB >> 20674535

Characteristics and survival associated with ovarian cancer diagnosed as first cancer and ovarian cancer diagnosed subsequent to a previous cancer.

Zahava Berkowitz1, Sun Hee Rim, Lucy A Peipins.   

Abstract

OBJECTIVE: To examine the risk of subsequent primary ovarian cancer among women diagnosed previously with cancer (subsequent cohort) and to compare demographic and tumor characteristics affecting overall survival of these women and women diagnosed with first primary ovarian cancer (index cohort).
METHODS: We identified the two cohorts of women using the 1973-2005 Surveillance, Epidemiology and End Results (SEER) result data. We calculated relative risk of subsequent primary ovarian cancer and estimated 5-year risks of dying (hazard-ratios) after diagnosis of the first or subsequent primary ovarian cancer in the two cohorts, respectively using Cox modeling.
RESULTS: Women diagnosed with index cancers of the corpus uteri, colon, cervix, and melanoma at age younger than 50 had increased risk of ovarian cancer within 5 years after diagnosis (p<0.05); young breast cancer survivors had continued risk beyond 20 years. In 5-year follow-up survival analysis, the factors associated with a better survival (p<0.05) were similar in both cohorts and included more recent diagnosis; localized or regional disease; age <50 years at diagnosis; and being white versus black. A lower risk of dying from mucinous, endometrioid, or non-epithelial tumors than from serous was seen after 15 months (p<0.01), or after 32 months from diagnosis of the index and subsequent cohorts, respectively.
CONCLUSIONS: Age, stage, and histology affect ovarian cancer survival. The increased risk of ovarian cancer over time, especially among breast and colon cancer survivors who are less than 50 years of age, suggests common etiologies and necessitates careful surveillance by health care providers and increased survivors awareness through educational efforts. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20674535     DOI: 10.1016/j.canep.2010.07.001

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Preventive care service use among cancer survivors with serious psychological distress: An analysis of the medical expenditure panel survey data.

Authors:  Sun Hee Rim; K Robin Yabroff; Sabitha Dasari; Xuesong Han; Kristin Litzelman; Donatus U Ekwueme
Journal:  Prev Med       Date:  2019-03-16       Impact factor: 4.018

2.  Formulation and evaluation of oral microparticulate ovarian cancer vaccines.

Authors:  Suprita A Tawde; Lipika Chablani; Archana Akalkotkar; Cherilyn D'Souza; Maurizio Chiriva-Internati; Periasamy Selvaraj; Martin J D'Souza
Journal:  Vaccine       Date:  2012-06-28       Impact factor: 3.641

3.  Declining second primary ovarian cancer after first primary breast cancer.

Authors:  Sara J Schonfeld; Amy Berrington de Gonzalez; Kala Visvanathan; Ruth M Pfeiffer; William F Anderson
Journal:  J Clin Oncol       Date:  2013-01-02       Impact factor: 44.544

4.  Expression of Toll-like receptor 4 in ovarian serous adenocarcinoma and correlation with clinical stage and pathological grade.

Authors:  Xue-Zhen Luo; Qi-Zhi He; Kai Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants.

Authors:  Lucia Del Mastro; Hatem A Azim; Matteo Lambertini; Marcello Ceppi; Anne-Sophie Hamy; Olivier Caron; Philip D Poorvu; Estela Carrasco; Albert Grinshpun; Kevin Punie; Christine Rousset-Jablonski; Alberta Ferrari; Shani Paluch-Shimon; Angela Toss; Claire Senechal; Fabio Puglisi; Katarzyna Pogoda; Jose Alejandro Pérez-Fidalgo; Laura De Marchis; Riccardo Ponzone; Luca Livraghi; Maria Del Pilar Estevez-Diz; Cynthia Villarreal-Garza; Maria Vittoria Dieci; Florian Clatot; Francois P Duhoux; Rossella Graffeo; Luis Teixeira; Octavi Córdoba; Amir Sonnenblick; Arlindo R Ferreira; Ann H Partridge; Antonio Di Meglio; Claire Saule; Fedro A Peccatori; Marco Bruzzone; Marie Daphne t'Kint de Roodenbeke; Lieveke Ameye; Judith Balmaña
Journal:  NPJ Breast Cancer       Date:  2021-02-12

6.  Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.

Authors:  Zhiyu Li; Qi Wu; Junlong Song; Yimin Zhang; Shan Zhu; Shengrong Sun
Journal:  Horm Cancer       Date:  2018-03-19       Impact factor: 3.869

7.  Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.

Authors:  Hyeong In Ha; Eun-Gyeong Lee; Jiwon Lim; So-Youn Jung; Yoon Jung Chang; Young-Joo Won; Myong Cheol Lim
Journal:  Cancer Res Treat       Date:  2020-11-18       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.